eFFECTOR Therapeutics, Inc.
EFTRDelisted Jul 19, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001828522
eFFECTOR Therapeutics, Inc. was delisted on Jul 19, 2024; its insiders filed their last Form 4 on Jun 13, 2024; 18 institutions reported holding it in 13F filings for Q2 2024, worth $251.1K in total; no superinvestor held it.
13F holders, Q4 2021
Institutional positions in eFFECTOR Therapeutics, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 18
- +6 vs. Q3 2021
- Shares held
- 21.4M
- +7.97M (+59.4%) vs. Q3 2021
- Total value
- $174.2M
- −$13.8M (−7.3%) vs. Q3 2021
- New holders
- 11
- 2 more added
- Sold out
- 5
- 2 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EFTR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $0 |
| Q1 2026 | 1 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 1 | $0 |
| Q1 2025 | 1 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 3 | $4.33K |
| Q2 2024 | 18 | $251.1K |
| Q1 2024 | 17 | $13.5M |
| Q4 2023 | 24 | $5.44M |
| Q3 2023 | 29 | $14.0M |
| Q2 2023 | 33 | $20.2M |
| Q1 2023 | 26 | $8.29M |
| Q4 2022 | 30 | $10.4M |
| Q3 2022 | 27 | $13.7M |
| Q2 2022 | 24 | $33.9M |
| Q1 2022 | 19 | $89.7M |
| Q4 2021 | 18 | $174.2M |
| Q3 2021 | 12 | $187.9M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding eFFECTOR Therapeutics, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Sr One Capital Management, LP | 6,822,114 | $56.5M | 31.92% | +6,822,114 | New |
| Abingworth LLP | 4,822,114 | $39.9M | 9.67% | 00.0% | Unchanged |
| The Column Group LLC | 4,309,329 | $35.7M | 4.85% | 00.0% | Unchanged |
| Sectoral Asset Management Inc | 2,382,744 | $19.7M | 2.97% | −500,000−17.3% | Reduced |
| OUP Management Co., LLC | 1,025,697 | $8.49M | 3.83% | +1,025,697 | New |
| Blackstone Group Inc. | 1,308,587 | $7.80M | 0.02% | 00.0% | Unchanged |
| Vanguard Group Inc | 516,164 | $4.27M | 0.00% | +516,164 | New |
| Geode Capital Management, LLC | 95,801 | $793.0K | 0.00% | +71,796+299.1% | Added |
| Alps Advisors Inc | 51,942 | $430.0K | 0.00% | +51,942 | New |
| Morgan Stanley | 28,678 | $237.0K | 0.00% | +28,578+28,578.0% | Added |
| Northern Trust Corp | 16,657 | $138.0K | 0.00% | +16,657 | New |
| Two Sigma Investments, LP | 14,122 | $117.0K | 0.00% | +14,122 | New |
| Penserra Capital Management LLC | 3,003 | $24.0K | 0.00% | +3,003 | New |
| UBS Group AG | 2,401 | $20.0K | 0.00% | +2,401 | New |
| BlackRock Inc. | 1,133 | $10.0K | 0.00% | +1,133 | New |
| Tower Research Capital LLC (TRC) | 737 | $7.00K | 0.00% | −6,122−89.3% | Reduced |
| JPMorgan Chase & Co | 780 | $6.00K | 0.00% | +780 | New |
| Wells Fargo & Company | 59 | $0 | 0.00% | +59 | New |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −24,667−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −18,304−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −17,444−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −13,277−100.0% | Sold out |
| Creative Financial Designs Inc | 0 | $0 | 0.00% | −430−100.0% | Sold out |